• 2N Pharma Joins BioInnovation Institute and Secures Funding of €1.3m

    PRESS RELEASE: Ground-breaking ALS start-up accepted into the Creation House program ofBioInnovation Institute (BII), securing funding of EUR 1.3 million Copenhagen, Denmark – September 22, 2020     The Bioinnovation Institute (BII) have accepted biotech start-up 2N Pharma into its Creation House program awarding the start-up EUR 1.3...
  • Meet us at LSX Nordic Congress 2019

    Meet us in Stockholm at the LSX Nordic Congress on 28-29 August 2019 at Nasdaq. We are very happy to meet with potential collaborators and investors, although we will be selective with the number of CROs...
  • Incorporation

    2N Pharma AB was incorporated in Sweden today to build on a decade of John Nieland's research in neurological disorders. This marks the formal beginning of the process to take potential therapies from preclinical results to...
  • 2N Pharma Founded

    2N Pharma was founded today by the experienced management team behind the clinical stage biotech company 2A Pharma AB. There is a long road ahead but we are excited to start the process of developing new...